Association of Coffee Consumption with Serum Adiponectin, Leptin, Inflammation and Metabolic Markers in Japanese Workers: a Cross-sectional Study
Overview
Nutritional Sciences
Affiliations
Background: Mechanisms underlying coffee's beneficial actions against cardiovascular disease and glucose metabolism are not well understood. Little information is available regarding association between coffee consumption and adipocytokines.
Objective: We investigated potential associations between coffee consumption and adiponectin, leptin, markers for subclinical inflammation, glucose metabolism, lipids and liver enzymes. We then investigated whether adipocytokines played a role in the association between coffee consumption and these markers.
Design And Subjects: This is a cross-sectional study comprising 2554 male and 763 female Japanese workers. Potential relations between coffee consumption and adipocytokines or other markers were evaluated using a multiple linear regression model adjusted for confounding factors. We evaluated whether adiponectin and leptin partly explain the associations between coffee consumption and each marker by multiple mediation analysis.
Results: Coffee consumption showed significant positive associations with adiponectin and total and low-density lipoprotein cholesterol, and inverse associations with leptin, high sensitivity C-reactive protein (hs-CRP), triglycerides and liver enzymes (all P<0.05). An adjustment for adiponectin and leptin significantly attenuated the associations between coffee consumption and hs-CRP or triglycerides, but not for liver enzymes. No associations were observed between coffee consumption and glucose metabolism-related markers.
Conclusion: Coffee consumption was associated with high adiponectin and low leptin levels. We speculated that adipocytokines mainly explain the associations of coffee consumption with lipids and hs-CRP. Factors other than adipocytokines may explain the association between coffee consumption and liver function.
Matsunaga T, Wakai K, Imaeda N, Goto C, Tamada Y, Kato Y Public Health Nutr. 2024; 27(1):e212.
PMID: 39420779 PMC: 11604322. DOI: 10.1017/S1368980024001599.
Meliani-Rodriguez A, Cutillas-Tolin A, Mendiola J, Sanchez-Ferrer M, De la Cruz-Sanchez E, Vioque J Nutrients. 2024; 16(14).
PMID: 39064680 PMC: 11279816. DOI: 10.3390/nu16142238.
Caffeine: a potential mechanism for anti-obesity.
Wang M, Guo W, Chen J Purinergic Signal. 2024; .
PMID: 38802651 DOI: 10.1007/s11302-024-10022-1.
Alshahrani S, Atia Y, Badir R, Almalki S, Tayyib N, Shahab S BMC Endocr Disord. 2023; 23(1):227.
PMID: 37864190 PMC: 10588058. DOI: 10.1186/s12902-023-01477-1.
Association between coffee consumption and high C-reactive protein levels in Korean adults.
Choi S, Je Y Br J Nutr. 2023; 130(12):2146-2154.
PMID: 37225668 PMC: 10657750. DOI: 10.1017/S0007114523001241.